Skip to main content

Animations

MJFF Publications

2331 - 2340 of 8808 Results
Title
Year
  • Year
  • 2010
  • 2009
  • 2011
  • 2011
  • 2014
  • 2012
  • 2018
  • 2015
  • 2008
  • 2012
  • Summary Details
    OPEN
    Title: Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2010.12.008
    Citation Count: 185
  • Summary Details
    OPEN
    Title: Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease
    Journal Name: Neurotoxicity Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s12640-009-9140-z
    Citation Count: 234
  • Summary Details
    OPEN
    Title: The alpha-synuclein 5′untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-010-0513-5
    Citation Count: 71
  • Summary Details
    OPEN
    Title: Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awr165
    Citation Count: 134
  • Summary Details
    OPEN
    Title: Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-Synuclein
    Journal Name: Applied Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/app4010066
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Discovery of Potent, Novel Nrf2 Inducers Via Quantum Modeling, Virtual Screening, and In Vitro Experimental Validation
    Journal Name: Chemical Biology & Drug Design
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/cbdd.12040
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Increasing the use of mobile technology–derived endpoints in clinical trials
    Journal Name: Clinical Trials
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1740774518755393
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2015.10.028
    Citation Count: 85
  • Summary Details
    OPEN
    Title: Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0705363105
    Citation Count: 249
  • Summary Details
    OPEN
    Title: Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/dds161
    Citation Count: 226
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.